Arcus Biosciences (RCUS) Short Interest Ratio & Short Volume $16.47 +0.74 (+4.70%) (As of 11/7/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Arcus Biosciences Short Interest DataArcus Biosciences (RCUS) has a short interest of 6.34 million shares, representing 13.19% of the float (the number of shares available for trading by the public). This marks a -4.08% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.1, indicating that it would take 10.1 days of the average trading volume of 734,657 shares to cover all short positions.Current Short Interest6,340,000 sharesPrevious Short Interest6,610,000 sharesChange Vs. Previous Month-4.08%Dollar Volume Sold Short$112.73 millionShort Interest Ratio10.1 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares91,430,000 sharesFloat Size48,070,000 sharesShort Percent of Float13.19%Today's Trading Volume2,495,273 sharesAverage Trading Volume734,657 sharesToday's Volume Vs. Average340% Short Selling Arcus Biosciences? Sign up to receive the latest short interest report for Arcus Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRCUS Short Interest Over TimeRCUS Days to Cover Over TimeRCUS Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Arcus Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20246,340,000 shares $112.73 million -4.1%13.2%10.1 $17.78 9/30/20246,610,000 shares $101.03 million -4.2%13.8%11.5 $15.29 9/15/20246,900,000 shares $123.86 million +2.4%14.2%11.5 $17.95 8/31/20246,740,000 shares $115.39 million -3.3%13.8%9.9 $17.12 8/15/20246,970,000 shares $109.64 million +5.3%14.4%9.6 $15.73 7/31/20246,620,000 shares $108.90 million -0.3%13.7%9.3 $16.45 Get the Latest News and Ratings for RCUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/15/20246,640,000 shares $102.52 million +7.8%13.8%9.4 $15.44 6/30/20246,160,000 shares $93.82 million -22.1%12.8%8.7 $15.23 6/15/20247,910,000 shares $134.23 million +6.5%16.4%11.4 $16.97 5/31/20247,430,000 shares $112.04 million -1.5%15.5%11.5 $15.08 5/15/20247,540,000 shares $132.33 million -2.7%15.7%11.3 $17.55 4/30/20247,750,000 shares $118.11 million +13.3%16.4%10.3 $15.24 4/15/20246,840,000 shares $111.42 million -17.1%14.5%8.3 $16.29 3/31/20248,250,000 shares $155.76 million +3.4%17.4%9.7 $18.88 3/15/20247,980,000 shares $151.78 million +3.9%16.9%9.3 $19.02 2/29/20247,680,000 shares $146.92 million +2.1%16.2%8.6 $19.13 2/15/20247,520,000 shares $123.37 million +7.4%15.9%8.6 $16.41 1/31/20247,000,000 shares $105.91 million -2.1%22.3%8.7 $15.13 1/15/20247,150,000 shares $125.20 million -1.7%14.8%9.1 $17.51 12/31/20237,270,000 shares $138.86 million +7.4%15.1%9.6 $19.10 12/15/20236,770,000 shares $122.67 million +2.9%14.0%8.6 $18.12 11/30/20236,580,000 shares $99.09 million +9.3%13.7%9.1 $15.06 11/15/20236,020,000 shares $87.59 million -13.0%12.5%7.8 $14.55 10/31/20236,920,000 shares $108.68 million +0.6%14.4%8.3 $15.71 10/15/20236,880,000 shares $110.91 million +3.9%14.4%8.7 $16.12 9/30/20236,620,000 shares $118.83 million +1.4%13.8%8 $17.95 9/15/20236,530,000 shares $134.39 million -11.0%13.6%8 $20.58 8/31/20237,340,000 shares $150.47 million +2.5%15.5%7.4 $20.50 8/15/20237,160,000 shares $128.67 million -1.1%15.1%6.6 $17.97 7/31/20237,240,000 shares $144.08 million -6.7%15.2%6.8 $19.90 7/15/20237,760,000 shares $169.94 million -1.7%16.7%7.2 $21.90 6/30/20237,890,000 shares $160.25 million -18.1%16.9%7.3 $20.31 6/15/20239,630,000 shares $188.75 million -6.0%20.2%9 $19.60 5/31/202310,240,000 shares $210.33 million +18.0%21.5%9.6 $20.54 5/15/20238,680,000 shares $169.43 million +11.1%18.3%9 $19.52 4/30/20237,810,000 shares $139.41 million -3.2%16.6%8.4 $17.85 4/15/20238,070,000 shares $141.55 million +5.1%17.1%8.4 $17.54 3/31/20237,680,000 shares $140.08 million +15.1%16.4%7.6 $18.24 3/15/20236,670,000 shares $113.12 million -10.7%14.2%5.5 $16.96 2/28/20237,470,000 shares $136.03 million +14.8%15.9%6.4 $18.21625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here 2/15/20236,510,000 shares $127.92 million +0.6%14.0%5.6 $19.65 1/31/20236,470,000 shares $139.95 million +1.3%14.0%5.5 $21.63 1/15/20236,390,000 shares $130.23 million -12.8%13.7%5.3 $20.38 12/30/20227,330,000 shares $151.58 million -2.5%15.7%6.6 $20.68 12/15/20227,520,000 shares $233.12 million -0.5%16.1%7.6 $31.00 11/30/20227,560,000 shares $265.89 million +7.7%16.2%9.6 $35.17 11/15/20227,020,000 shares $210.95 million +4.8%15.1%10.3 $30.05 10/31/20226,700,000 shares $170.72 million -19.1%15.0%9.8 $25.48 10/15/20228,280,000 shares $220.58 million +1.4%18.6%13 $26.64 9/30/20228,170,000 shares $213.73 million -3.1%18.3%12.8 $26.16 9/15/20228,430,000 shares $226.43 million -0.5%18.9%12.6 $26.86 8/31/20228,470,000 shares $203.96 million +3.2%19.0%12.1 $24.08 8/15/20228,210,000 shares $229.88 million +4.7%18.4%10.5 $28.00 7/31/20227,840,000 shares $208.47 million +5.0%19.6%7.6 $26.59 7/15/20227,470,000 shares $216.93 million +4.5%17.0%7 $29.04 6/30/20227,150,000 shares $181.18 million +4.5%16.2%6.5 $25.34 6/15/20226,840,000 shares $148.15 million -2.8%15.5%4.8 $21.66 5/31/20227,040,000 shares $133.41 million -11.7%16.0%5.3 $18.95 5/15/20227,970,000 shares $154.38 million -14.9%18.1%6 $19.37 4/30/20229,370,000 shares $226.85 million +10.8%21.0%8.8 $24.21 4/15/20228,460,000 shares $270.55 million +48.2%19.0%8.5 $31.98 3/31/20225,710,000 shares $180.21 million +5.6%12.9%5.7 $31.56 3/15/20225,410,000 shares $171.23 million -5.6%12.1%8.3 $31.65 2/28/20225,730,000 shares $213.16 million -1.4%12.9%8.3 $37.20 2/15/20225,810,000 shares $172.56 million -4.4%13.2%8.6 $29.70 1/31/20226,080,000 shares $187.26 million -8.7%15.2%8.3 $30.80 1/15/20226,660,000 shares $238.49 million -20.6%15.8%9.6 $35.81 12/31/20218,390,000 shares $339.54 million +18.5%19.9%13.3 $40.47 12/15/20217,080,000 shares $286.88 million -5.2%16.8%10.9 $40.52 11/30/20217,470,000 shares $327.19 million +1.1%17.6%12.4 $43.80 11/15/20217,390,000 shares $281.34 million No Change17.4%13.3 $38.07 10/29/20217,390,000 shares $247.12 million +1.9%17.1%16.5 $33.44 10/15/20217,250,000 shares $249.33 million +2.1%16.8%16.1 $34.39 9/30/20217,100,000 shares $247.58 million -4.8%16.5%14.1 $34.87 9/15/20217,460,000 shares $248.94 million -2.7%17.4%11.6 $33.37 8/31/20217,670,000 shares $223.73 million -0.8%18.0%12.1 $29.17 8/13/20217,730,000 shares $211.57 million -0.9%18.1%11.7 $27.37 7/30/20217,800,000 shares $245.00 million +8.5%18.4%11.1 $31.41 7/15/20217,190,000 shares $205.49 million +6.2%17.0%10.1 $28.58 6/30/20216,770,000 shares $185.90 million +4.3%16.0%9.8 $27.46 6/15/20216,490,000 shares $158.03 million +0.3%15.3%10.4 $24.35 5/28/20216,470,000 shares $160.59 million +5.2%15.3%12.3 $24.82 5/14/20216,150,000 shares $170.05 million +11.4%14.5%11.8 $27.65 4/30/20215,520,000 shares $184.48 million -3.0%13.1%10.3 $33.42 4/15/20215,690,000 shares $188.96 million -6.7%13.5%10.9 $33.21 3/31/20216,100,000 shares $171.17 million +3.6%14.5%11.4 $28.06 3/15/20215,890,000 shares $214.69 million No Change14.0%11.1 $36.45 2/26/20215,890,000 shares $201.73 million -0.2%14.9%11.5 $34.25 2/12/20215,900,000 shares $218.30 million -1.5%16.3%11.9 $37.00 1/29/20215,990,000 shares $212.11 million -5.2%16.5%12.6 $35.41625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here 1/15/20216,320,000 shares $245.41 million +7.5%15.1%12.1 $38.83 12/31/20205,880,000 shares $159.64 million -6.8%13.9%11.7 $27.15 12/15/20206,310,000 shares $202.61 million -2.2%14.9%13 $32.11 11/30/20206,450,000 shares $165.83 million -2.9%15.2%12.4 $25.71 11/15/20206,640,000 shares $150.06 million -2.5%15.7%12.6 $22.60 10/30/20206,810,000 shares $159.49 million -2.9%16.1%12.1 $23.42 10/15/20207,010,000 shares $137.19 million +8.4%17.3%13.8 $19.57 9/30/20206,470,000 shares $110.90 million +19.8%16.5%12.3 $17.14 9/15/20205,400,000 shares $114.53 million +3.5%13.7%8.9 $21.21 8/31/20205,220,000 shares $124.24 million +3.6%13.3%8.3 $23.80 8/14/20205,040,000 shares $119.85 million +13.0%14.1%6.5 $23.78 7/31/20204,460,000 shares $87.77 million +7.7%13.2%5.6 $19.68 7/15/20204,140,000 shares $96.83 million +23.2%13.9%5 $23.39 6/30/20203,360,000 shares $79.40 million +101.2%8.9%3.7 $23.63 6/15/20201,670,000 shares $46.46 million +9.2%4.4%2 $27.82 5/29/20201,530,000 shares $47.97 million +260.0%4.6%2.1 $31.35 5/15/2020425,000 shares $14.89 million +28.2%1.6%0.7 $35.03 4/30/2020331,600 shares $8.76 million -50.7%1.2%0.6 $26.41 4/15/2020672,900 shares $10.48 million -7.8%2.5%1.4 $15.58 3/31/2020730,000 shares $21.17 million -23.0%2.7%2.3 $29.00 3/13/2020948,200 shares $15.10 million -37.6%2.9%3.8 $15.93 2/28/20201,520,000 shares $15.96 million +22.6%5.6%6.1 $10.50 2/14/20201,240,000 shares $21.74 million -3.9%4.6%6.3 $17.53 1/31/20201,290,000 shares $19.69 million -9.8%4.5%10.3 $15.26 1/15/20201,430,000 shares $16.42 million No Change5.0%12.9 $11.48 12/31/20191,430,000 shares $13.41 million -1.4%5.0%8.9 $9.38 RCUS Short Interest - Frequently Asked Questions What is Arcus Biosciences' current short interest? Short interest is the volume of Arcus Biosciences shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 6,340,000 shares of RCUS short. 13.19% of Arcus Biosciences' shares are currently sold short. Learn More on Arcus Biosciences' current short interest. What is a good short interest ratio for Arcus Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCUS shares currently have a short interest ratio of 10.0. Learn More on Arcus Biosciences's short interest ratio. What is a good short interest percentage for Arcus Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.19% of Arcus Biosciences' floating shares are currently sold short. Is Arcus Biosciences' short interest increasing or decreasing? Arcus Biosciences saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 6,340,000 shares, a decline of 4.1% from the previous total of 6,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Arcus Biosciences' float size? Arcus Biosciences currently has issued a total of 91,430,000 shares. Some of Arcus Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcus Biosciences currently has a public float of 48,070,000 shares. How does Arcus Biosciences' short interest compare to its competitors? 13.19% of Arcus Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Arcus Biosciences: Krystal Biotech, Inc. (12.32%), Avidity Biosciences, Inc. (13.55%), Biohaven Ltd. (9.87%), Ultragenyx Pharmaceutical Inc. (3.43%), BridgeBio Pharma, Inc. (12.10%), Arcellx, Inc. (10.33%), Crinetics Pharmaceuticals, Inc. (8.23%), Immunovant, Inc. (20.84%), ADMA Biologics, Inc. (6.89%), Organon & Co. (4.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Arcus Biosciences stock? Short selling RCUS is an investing strategy that aims to generate trading profit from Arcus Biosciences as its price is falling. RCUS shares are trading up $0.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arcus Biosciences? A short squeeze for Arcus Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RCUS, which in turn drives the price of the stock up even further. How often is Arcus Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCUS, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies KRYS Short Interest RNA Short Interest BHVN Short Interest RARE Short Interest BBIO Short Interest ACLX Short Interest CRNX Short Interest IMVT Short Interest ADMA Short Interest OGN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:RCUS) was last updated on 11/8/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredThe secret supplier behind NVIDIA, Tesla and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredUrgent: This election is riggedI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | SponsoredWhat Trump’s victory means for GOLDGold may have suffered a pullback after news of Trump's 2024 election win spread... But don't be mistaken: ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
